Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF

BACKGROUND: Compared to heart failure patients with higher systolic blood pressure (SBP), those with lower SBP have a worse prognosis. To make matters worse, the latter patients often do not receive treatment with life-saving therapies that might lower blood pressure further. We examined the associa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur Heart J
Auteurs principaux: Böhm, Michael, Young, Robin, Jhund, Pardeep S., Solomon, Scott D., Gong, Jianjian, Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Swedberg, Karl, Zile, Michael R., Packer, Milton, McMurray, John J.V.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Clinical Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6251522/
https://ncbi.nlm.nih.gov/pubmed/28158398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehw570
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires